%0 Journal Article %A Gerard de Vries %A Sarah van de Berg %A Anke van Dam %A Sayohat Hasanova %A Manish Pareek %A Marieke J. van der Werf %A Daria N. Podlekareva %A , %T Collaborative TB/HIV activities in the European Region %D 2020 %R 10.1183/23120541.00721-2020 %J ERJ Open Research %P 00721-2020 %X Introduction An estimated 12% of tuberculosis (TB) patients are coinfected with HIV in the World Health Organisation European Region (Region). Reducing morbidity and mortality from HIV-associated TB requires strong collaboration between TB and HIV services at all levels with integrated people-centred models of care.Methods We collected information on the current models of integration of TB and HIV services in the Region via a comprehensive survey among the TB and HIV National Focal Points, and identified challenges and opportunities.Results Forty-seven of 55 countries (85%) responded. HIV testing in all TB patients and screening for active TB in all people living with HIV (PLHIV) was recommended in 40 (85%) and 34 (72%) respectively. Thirty countries (64%) recommended latent TB infection (LTBI) screening in all PLHIV, while 13 (28%) had a selective approach and 4 countries (9%) did not recommend LTBI screening. In most countries testing for HIV and screening for active TB and LTBI was done by the specialist that is treating the patient, i.e. TB patients were tested for HIV by a TB specialist in 42 countries (89%) and PLHIV were screened for active TB by an HIV specialist in 34 countries (72%).Conclusion TB and HIV care are well integrated in policies of especially high TB and high HIV burden countries. Implementation though needs to be improved. Continuous monitoring of HIV and TB services integration enables assessing the quality of HIV/TB care and to identify where further improvements are needed.FootnotesThis manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.Conflict of interest: Dr. de Vries has nothing to disclose.Conflict of interest: Ms. van de Berg has nothing to disclose.Conflict of interest: Dr. van Dam has nothing to disclose.Conflict of interest: Dr. Hasanova has nothing to disclose.Conflict of interest: Dr. Pareek reports grants and personal fees from Gilead Sciences, personal fees from QIAGEN, outside the submitted work;.Conflict of interest: Dr. van der Werf has nothing to disclose.Conflict of interest: Dr. Podlekareva has nothing to disclose. %U https://openres.ersjournals.com/content/erjor/early/2020/10/29/23120541.00721-2020.full.pdf